Warning: fopen(/home/virtual/kjme/journal/upload/ip_log/ip_log_2026-01.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 97 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 98
, Daniel D. Kim1,*
, Juliana E. Kim2
, Elliott Rebello1
, David Chung1
, Parker Woolley1
, Daniel Lee3
, Brittany A. Borden1
, Aaron Wang1
, Douglas Villalta1
, Agatha Sutherland1
, Sebastian De Armas4
, Matthew Liu1
, Hannah Kim5
, Grace Sora Ahn6
, Reed Geisler7
, Alexander Yang8
, Bowon Joung4
, John Slate-Romano1
, Michal Rajski1
, Alison E. Kim1
, Roxanne Vrees1
, Kristina Monteiro1
1Office of Medical Education, Warren Alpert Medical School, Brown University, Providence, RI, USA
2School of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
3School of Medicine, Morehouse School of Medicine, Atlanta, GA, USA
4School of Medicine, Loma Linda University, Loma Linda, CA, USA
5School of Medicine, Oregon Health and Science University, Portland, OR, USA
6School of Medicine, University of California San Diego, San Diego, CA, USA
7College of Medicine, The Ohio State University, Columbus, OH, USA
8School of Medicine, Yale University, New Haven, CT, USA
© The Korean Society of Medical Education.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Funding
None.
Conflicts of interest
No potential conflict of interest relevant to this article was reported.
Author contributions
Conception: IEK, DDK, JEK; design of the study: IEK, DDK, JEK, ER, DC, PW, DL, DV, MR; data acquisition: JEK, ER, DC, PW, DL, BB, AW, DV, AS, SDA, ML, HK, GSA, RG, AY, BJ, JSR, MR, AEK; data interpretation: IEK, DDK, PW; statistics: KM; drafting and editing the article: all authors; supervision of the project: RV, KM; and final approval of the version to be published: all authors.
| Demographic characteristic | Dissatisfied | Neutral | Satisfied | p-value |
|---|---|---|---|---|
| All | 94 (21.9) | 69 (16.0) | 266 (61.9) | - |
| Year | 0.002a) | |||
| 2 | 1 (7.1) | 2 (14.3) | 11 (78.6) | |
| 3 | 76 (26.4) | 50 (17.4) | 162 (56.2) | |
| 4 | 17 (13.4) | 17 (13.4) | 93 (73.2) | |
| Race | 0.371a) | |||
| Asian/Pacific Islander | 23 (20.9) | 18 (16.4) | 69 (62.7) | |
| Black or African American | 12 (22.6) | 9 (17.0) | 32 (60.4) | |
| Hispanic or Latino | 4 (12.9) | 3 (9.7) | 24 (77.4) | |
| White | 43 (21.5) | 36 (18.0) | 121 (60.5) | |
| None of the above/mixed | 12 (34.3) | 3 (8.6) | 20 (57.1) | |
| Gender | 0.038a) | |||
| Female | 66 (27.8) | 29 (12.2) | 142 (59.9) | |
| Male | 28 (15.0) | 37 (19.8) | 122 (65.2) | |
| Non-binary/non-conforming | 0 | 3 (75.0) | 1 (25.0) | |
| Prefer not to respond | 0 | 0 | 1 (100.0) | |
| Self-perceived socioeconomic status | 0.993a) | |||
| Lower class | 5 (25.0) | 2 (10.0) | 13 (65.0) | |
| Lower middle class | 17 (25.4) | 7 (10.4) | 43 (64.2) | |
| Middle class | 27 (20.9) | 27 (20.9) | 75 (58.1) | |
| Upper middle class | 36 (20.8) | 31 (17.9) | 106 (61.3) | |
| Upper class | 9 (23.7) | 2 (5.3) | 27 (71.1) | |
| Region | 0.005a) | |||
| Midwest | 15 (24.6) | 12 (19.7) | 34 (55.7) | |
| Northeast | 14 (15.4) | 12 (13.2) | 65 (71.4) | |
| South | 43 (29.5) | 28 (19.2) | 75 (51.4) | |
| West | 22 (16.8) | 17 (13.0) | 92 (70.2) | |
| Categorized as | 0.238a) | |||
| Healthcare worker | 31 (20.4) | 15 (9.9) | 106 (69.7) | |
| Student | 63 (22.7) | 54 (19.5) | 160 (57.8) | |
| Vaccine status | 0.001a) | |||
| Vaccinated/will receive earlier than general population | 86 (20.7) | 67 (16.1) | 262 (63.1) | |
| Will receive same time as general population/unsure | 8 (57.1) | 2 (14.3) | 4 (28.6) | |
| Testing status | <0.001 | |||
| Both clinical and preclinical students tested | 21 (16.7) | 16 (12.7) | 89 (70.6) | |
| Clinical students tested; pre-clinical students not tested | 28 (11.8) | 50 (21.1) | 159 (67.1) | |
| Clinical students not tested; pre-clinical students tested | 25 (80.6) | 4 (12.9) | 2 (6.5) | |
| Both clinical and preclinical students not tested | 15 (41.7) | 14 (38.9) | 7 (19.4) | |
| Age (yr) | 26 (25–27) | 26 (25–27) | 26 (25–27) | 0.565b) |
| Medical school enrollment size | 746 (602–750) | 679 (598–750) | 624 (598–746) | 0.002b) |
Data are presented as number (%) or median (interquartile range). Satisfaction reported with the “testing status” variable is satisfaction with coronavirus disease 2019 testing.
a)Derived using the Pearson chi-square test (neutral responses are excluded).
b)Derived using the Wilcoxon rank-sum test (neutral responses as excluded).
| Logistic regression model | OR (95% CI) | p-value |
|---|---|---|
| Overall satisfaction model (n=224) | ||
| Satisfied with school communicationa) | 69.058 (17.898–266.449 | <0.001 |
| Satisfied with exposure to COVID-19a) | 30.413 (5.475–168.938) | <0.001 |
| Satisfied with PPE availabilitya) | 3.078 (0.517–18.345) | 0.217 |
| Satisfied with access to COVID-19 testinga) | 4.283 (1.268–14.463) | 0.019 |
| Adjusted overall satisfaction model with demographic characteristics significant in chi-square and rank sum analysis (n=224) | ||
| Satisfied with school communicationa) | 70.013 (15.424–317.797) | <0.001 |
| Satisfied with exposure to COVID-19a) | 37.787 (7.154–199.598) | <0.001 |
| Satisfied with PPE availabilitya) | 4.087 (0.508–32.906) | 0.186 |
| Satisfied with access to COVID-19 testinga) | 3.239 (0.756–13.887) | 0.114 |
| Year: third-year student | 0.301 (0.071–1.269) | 0.102 |
| Region | 0.081 | |
| Northeast | 0.060 (0.003–1.104) | 0.058 |
| South | 0.091 (0.008–0.988) | 0.049 |
| West | 0.750 (0.068–8.312) | 0.815 |
| Medical school size | 0.992 (0.984–1.000) | 0.061 |
| Vaccine status | ||
| Will receive same time as general population/unsure | 0.065 (0.000–14.565) | 0.323 |
| School communication satisfaction model (n=355) | ||
| No. of important messages | 2.565 (1.982–3.319) | <0.001 |
| Exposure to COVID-19 satisfaction model (n=349) | ||
| Policy exists for rotations if quarantine needed | 2.155 (1.046–4.440) | 0.037 |
| Extent to which agree: comfortable with sharing positive results to schoolb) | 1.551 (1.171–2.054) | 0.002 |
| Extent to which agree: experience discomfort due to improper PPE usage by peersb) | 0.386 (0.268–0.554) | <0.001 |
| Frequency of exposure to COVID-19 patientsb) | 0.625 (0.392–0.996) | 0.048 |
| PPE availability satisfaction model (n=398) | ||
| Extent to which agree: adequate/accessible PPEb) | 15.518 (6.829–35.261) | <0.001 |
| Extent to which agree: properly trained to use PPEb) | 4.149 (2.565–6.711) | <0.001 |
| Access to COVID-19 testing satisfaction model (n=346) | ||
| Access to COVID-19 testing if desired | 5.682 (2.213–14.590) | <0.001 |
| COVID-19 testing frequencyb) | 3.115 (2.038–4.760) | <0.001 |
| Regular testing of first- and second-year students | 0.303 (0.153–0.598) | 0.001 |
| COVID-19 symptoms required or unsure if required for testing | 0.442 (0.212–0.922) | 0.030 |
OR: Odds ratio, CI: Confidence interval, COVID-19: Coronavirus disease 2019, PPE: Personal protective equipment.
a)Dichotomized variable.
b)Categorical Likert scale variable that was coded continuously numerically (i.e., 1=strongly disagree, 2=somewhat disagree, 3=neither disagree nor agree, 4=somewhat agree, 5=strongly agree; or 0=never, 1=weekly).
| Demographic characteristic | Value |
|---|---|
| All | 430 |
| Year | |
| 2 | 14 (3.3) |
| 3 | 288 (67.0) |
| 4 | 128 (29.8) |
| Race | |
| Asian/Pacific Islander | 110 (25.6) |
| Black or African American | 53 (12.3) |
| Hispanic or Latino | 31 (7.2) |
| White | 201 (46.7) |
| None of the above/mixed | 35 (8.1) |
| Gender | |
| Female | 238 (55.3) |
| Male | 187 (43.5) |
| Non-binary/non-conforming | 4 (0.9) |
| Prefer not to respond | 1 (0.2) |
| Self-perceived socioeconomic status | |
| Lower class | 20 (4.7) |
| Lower middle class | 67 (15.6) |
| Middle class | 129 (30.0) |
| Upper middle class | 38 (8.8) |
| Upper class | 174 (40.5) |
| Region | |
| Midwest | 61 (14.2) |
| Northeast | 92 (21.4) |
| South | 146 (34.0) |
| West | 131 (30.5) |
| Categorized as | |
| Healthcare worker | 153 (35.6) |
| Student | 277 (64.4) |
| Vaccine status | |
| Vaccinated/will receive earlier than general population | 416 (96.7) |
| Will receive same time as general population/unsure | 14 (3.3) |
| Age (yr) | 26 (25–27) |
| Medical school enrollment size | 624 (598–750) |
| Demographic characteristic | Dissatisfied | Neutral | Satisfied | p-value |
|---|---|---|---|---|
| All | 94 (21.9) | 69 (16.0) | 266 (61.9) | - |
| Year | 0.002a) | |||
| 2 | 1 (7.1) | 2 (14.3) | 11 (78.6) | |
| 3 | 76 (26.4) | 50 (17.4) | 162 (56.2) | |
| 4 | 17 (13.4) | 17 (13.4) | 93 (73.2) | |
| Race | 0.371a) | |||
| Asian/Pacific Islander | 23 (20.9) | 18 (16.4) | 69 (62.7) | |
| Black or African American | 12 (22.6) | 9 (17.0) | 32 (60.4) | |
| Hispanic or Latino | 4 (12.9) | 3 (9.7) | 24 (77.4) | |
| White | 43 (21.5) | 36 (18.0) | 121 (60.5) | |
| None of the above/mixed | 12 (34.3) | 3 (8.6) | 20 (57.1) | |
| Gender | 0.038a) | |||
| Female | 66 (27.8) | 29 (12.2) | 142 (59.9) | |
| Male | 28 (15.0) | 37 (19.8) | 122 (65.2) | |
| Non-binary/non-conforming | 0 | 3 (75.0) | 1 (25.0) | |
| Prefer not to respond | 0 | 0 | 1 (100.0) | |
| Self-perceived socioeconomic status | 0.993a) | |||
| Lower class | 5 (25.0) | 2 (10.0) | 13 (65.0) | |
| Lower middle class | 17 (25.4) | 7 (10.4) | 43 (64.2) | |
| Middle class | 27 (20.9) | 27 (20.9) | 75 (58.1) | |
| Upper middle class | 36 (20.8) | 31 (17.9) | 106 (61.3) | |
| Upper class | 9 (23.7) | 2 (5.3) | 27 (71.1) | |
| Region | 0.005a) | |||
| Midwest | 15 (24.6) | 12 (19.7) | 34 (55.7) | |
| Northeast | 14 (15.4) | 12 (13.2) | 65 (71.4) | |
| South | 43 (29.5) | 28 (19.2) | 75 (51.4) | |
| West | 22 (16.8) | 17 (13.0) | 92 (70.2) | |
| Categorized as | 0.238a) | |||
| Healthcare worker | 31 (20.4) | 15 (9.9) | 106 (69.7) | |
| Student | 63 (22.7) | 54 (19.5) | 160 (57.8) | |
| Vaccine status | 0.001a) | |||
| Vaccinated/will receive earlier than general population | 86 (20.7) | 67 (16.1) | 262 (63.1) | |
| Will receive same time as general population/unsure | 8 (57.1) | 2 (14.3) | 4 (28.6) | |
| Testing status | <0.001 | |||
| Both clinical and preclinical students tested | 21 (16.7) | 16 (12.7) | 89 (70.6) | |
| Clinical students tested; pre-clinical students not tested | 28 (11.8) | 50 (21.1) | 159 (67.1) | |
| Clinical students not tested; pre-clinical students tested | 25 (80.6) | 4 (12.9) | 2 (6.5) | |
| Both clinical and preclinical students not tested | 15 (41.7) | 14 (38.9) | 7 (19.4) | |
| Age (yr) | 26 (25–27) | 26 (25–27) | 26 (25–27) | 0.565b) |
| Medical school enrollment size | 746 (602–750) | 679 (598–750) | 624 (598–746) | 0.002b) |
| Logistic regression model | OR (95% CI) | p-value |
|---|---|---|
| Overall satisfaction model (n=224) | ||
| Satisfied with school communicationa) | 69.058 (17.898–266.449 | <0.001 |
| Satisfied with exposure to COVID-19a) | 30.413 (5.475–168.938) | <0.001 |
| Satisfied with PPE availabilitya) | 3.078 (0.517–18.345) | 0.217 |
| Satisfied with access to COVID-19 testinga) | 4.283 (1.268–14.463) | 0.019 |
| Adjusted overall satisfaction model with demographic characteristics significant in chi-square and rank sum analysis (n=224) | ||
| Satisfied with school communicationa) | 70.013 (15.424–317.797) | <0.001 |
| Satisfied with exposure to COVID-19a) | 37.787 (7.154–199.598) | <0.001 |
| Satisfied with PPE availabilitya) | 4.087 (0.508–32.906) | 0.186 |
| Satisfied with access to COVID-19 testinga) | 3.239 (0.756–13.887) | 0.114 |
| Year: third-year student | 0.301 (0.071–1.269) | 0.102 |
| Region | 0.081 | |
| Northeast | 0.060 (0.003–1.104) | 0.058 |
| South | 0.091 (0.008–0.988) | 0.049 |
| West | 0.750 (0.068–8.312) | 0.815 |
| Medical school size | 0.992 (0.984–1.000) | 0.061 |
| Vaccine status | ||
| Will receive same time as general population/unsure | 0.065 (0.000–14.565) | 0.323 |
| School communication satisfaction model (n=355) | ||
| No. of important messages | 2.565 (1.982–3.319) | <0.001 |
| Exposure to COVID-19 satisfaction model (n=349) | ||
| Policy exists for rotations if quarantine needed | 2.155 (1.046–4.440) | 0.037 |
| Extent to which agree: comfortable with sharing positive results to schoolb) | 1.551 (1.171–2.054) | 0.002 |
| Extent to which agree: experience discomfort due to improper PPE usage by peersb) | 0.386 (0.268–0.554) | <0.001 |
| Frequency of exposure to COVID-19 patientsb) | 0.625 (0.392–0.996) | 0.048 |
| PPE availability satisfaction model (n=398) | ||
| Extent to which agree: adequate/accessible PPEb) | 15.518 (6.829–35.261) | <0.001 |
| Extent to which agree: properly trained to use PPEb) | 4.149 (2.565–6.711) | <0.001 |
| Access to COVID-19 testing satisfaction model (n=346) | ||
| Access to COVID-19 testing if desired | 5.682 (2.213–14.590) | <0.001 |
| COVID-19 testing frequencyb) | 3.115 (2.038–4.760) | <0.001 |
| Regular testing of first- and second-year students | 0.303 (0.153–0.598) | 0.001 |
| COVID-19 symptoms required or unsure if required for testing | 0.442 (0.212–0.922) | 0.030 |
Data are presented as number (%) or median (interquartile range).
Data are presented as number (%) or median (interquartile range). Satisfaction reported with the “testing status” variable is satisfaction with coronavirus disease 2019 testing.
Derived using the Pearson chi-square test (neutral responses are excluded).
Derived using the Wilcoxon rank-sum test (neutral responses as excluded).
OR: Odds ratio, CI: Confidence interval, COVID-19: Coronavirus disease 2019, PPE: Personal protective equipment.
Dichotomized variable.
Categorical Likert scale variable that was coded continuously numerically (i.e., 1=strongly disagree, 2=somewhat disagree, 3=neither disagree nor agree, 4=somewhat agree, 5=strongly agree; or 0=never, 1=weekly).